Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics of Sugammadex for the Reversal of Moderate Neuromuscular Blockade in Patients During Renal Transplantation

NCT05187455 is registered in ClinicalTrials.gov with Guangzhou General Hospital of Guangzhou Military Command as lead sponsor.

NCT NCT05187455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05187455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics of Sugammadex for the Reversal of Moderate Neuromuscular Blockade in Patients During Renal Transplantation
Lead sponsor
Guangzhou General Hospital of Guangzhou Military Command
Phase
Phase 4
Overall status
Unknown status
Start date
January 5, 2022
Completion date
November 30, 2022
Enrollment
34 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacokinetics